JIN MEDICAL INTERNATIONAL LT (ZJYL) Stock Balance Sheet
NASDAQ:ZJYL - Nasdaq - KYG5140V1124 - Common Stock - Currency: USD
| 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | 2020 (2020-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 8.14M | 6.93M | 4.79M | 3.67M | 1.66M | |||
| Marketable Securities | 18.62M | 9.77M | 2.28M | 2.05M | 1.18M | |||
| Receivables | 8.78M | 8.50M | 4.25M | 5.98M | 7.66M | |||
| Inventories | 5.17M | 5.05M | 6.72M | 6.89M | 6.98M | |||
| Other Current Assets | 2.11M | 864.00K | 858.00K | 821.00K | 672.00K | |||
| Total Current Assets | 42.82M | 31.12M | 18.90M | 19.42M | 18.16M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.72M | 1.48M | 1.63M | 2.11M | 2.31M | |||
| Intangibles | 1.15M | 154.00K | 163.00K | 185.00K | 181.00K | |||
| Other Non-Current Assets | 121.30K | 152.00K | 245.00K | 183.00K | 172.00K | |||
| Total Non-Current Assets | 2.98M | 1.79M | 2.04M | 2.48M | 2.66M | |||
| TOTAL ASSETS | 45.80M | 32.90M | 20.94M | 21.90M | 20.82M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 11.32M | 4.11M | 0.00 | 0.00 | 2.65M | |||
| Accrued Expenses | 185.20K | N/A | N/A | N/A | N/A | |||
| Accounts Payable | 3.44M | 3.71M | 4.51M | 6.07M | 5.63M | |||
| Other Current Liabilities | 2.20M | 1.10M | 1.20M | 1.80M | 1.73M | |||
| Total Current Liabilities | 17.15M | 8.92M | 5.70M | 7.87M | 10.01M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 96.20K | N/A | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | -166.50K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 16.99M | 8.92M | 5.70M | 7.87M | 10.01M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 22.61M | 18.94M | 16.06M | 13.35M | 10.72M | |||
| Additional Paid In Capital | 6.75M | 6.44M | 80.00K | 80.00K | 67.00K | |||
| Minority Interest | -262.70K | N/A | N/A | N/A | N/A | |||
| Common Shares | 7.80K | 8.00K | 7.00K | 7.00K | 20.00K | |||
| Other Shareholders' Equity | -556.20K | -1.40M | -911.00K | 589.00K | -6.00K | |||
| Shares Outstanding | 156.55M | 155.95M | 160.00M | 160.00M | 160.00M | |||
| Tangible Book Value per Share | 0.18 | 0.15 | 0.09 | 0.09 | 0.07 | |||
| Total Shareholders' Equity | 28.82M | 23.98M | 15.24M | 14.03M | 10.80M | |||
| TOTAL LIABILITIES AND EQUITY | 45.80M | 32.90M | 20.94M | 21.90M | 20.82M | |||
| Statistics | ||||||||
| Current Ratio | 2.50 | 3.49 | 3.31 | 2.47 | 1.81 | |||
| Return On Assets (ROA) | 8.03% | 8.75% | 12.93% | 12.02% | 10.60% | |||
| Return On Equity (ROE) | 12.76% | 12.00% | 17.77% | 18.76% | 20.42% | |||
| Return On Invested Capital (ROIC) | 7.79% | 8.73% | 11.96% | 16.05% | 14.98% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 14.58% | 13.38% | 14.06% | 18.80% | 16.41% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 15.41% | 13.50% | 14.24% | 19.09% | 16.66% | |||
All data in USD , ROIC based on taxRate of 0.14